Connie Mixon - MYCELX Technologies CEO Director
MYX Stock | 37.50 1.50 4.17% |
CEO
Connie Mixon is CEO Director of MYCELX Technologies
Age | 69 |
Address | 1650 International Court, Norcross, GA, United States, 30093 |
Phone | 770 534 3118 |
Web | https://mycelx.com |
MYCELX Technologies Management Efficiency
The company has return on total asset (ROA) of (0.2482) % which means that it has lost $0.2482 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4697) %, meaning that it generated substantial loss on money invested by shareholders. MYCELX Technologies' management efficiency ratios could be used to measure how well MYCELX Technologies manages its routine affairs as well as how well it operates its assets and liabilities. At present, MYCELX Technologies' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 12.2 M, whereas Other Current Assets are forecasted to decline to about 309.7 K.Similar Executives
Found 5 records | CEO Age | ||
Jason Hollar | Cardinal Health | 51 | |
James Risoleo | Host Hotels Resorts | 68 | |
Mark ACA | Primary Health Properties | 50 | |
Taylor CPA | Omega Healthcare Investors | 62 | |
Steve CBE | Hilton Food Group | 59 |
Management Performance
Return On Equity | -0.47 | ||||
Return On Asset | -0.25 |
MYCELX Technologies Leadership Team
Elected by the shareholders, the MYCELX Technologies' board of directors comprises two types of representatives: MYCELX Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MYCELX. The board's role is to monitor MYCELX Technologies' management team and ensure that shareholders' interests are well served. MYCELX Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MYCELX Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Haluk Alper, President, CoFounder | ||
Alexander Millar, Chief Arabia | ||
Kimberly Slayton, CFO Secretary | ||
John Sr, CoFounder Emeritus | ||
Connie Mixon, CEO Director |
MYCELX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MYCELX Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.47 | ||||
Return On Asset | -0.25 | ||||
Profit Margin | (0.40) % | ||||
Operating Margin | (0.61) % | ||||
Current Valuation | 8.56 M | ||||
Shares Outstanding | 24.36 M | ||||
Shares Owned By Insiders | 19.25 % | ||||
Shares Owned By Institutions | 41.80 % | ||||
Price To Book | 2.00 X | ||||
Price To Sales | 1.03 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in MYCELX Stock
MYCELX Technologies financial ratios help investors to determine whether MYCELX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MYCELX with respect to the benefits of owning MYCELX Technologies security.